Retailers, restaurants, apparel, packaged goods, household brands, and the consumer spending signals behind them.
Investors pushed up Starbucks stock on Thursday after an analyst said the company is beginning to shift from stabilizing performance to more aggressive growth actions in its turnaround effort.
THE APEX TIMES
THE APEX TIMES
Starbucks reported a fiscal third-quarter adjusted earnings result above analyst expectations and said comparable sales increased, sending its stock higher and prompting management to lift its fiscal 2026 outlook.
THE APEX TIMES
Starbucks reported a better-than-expected fiscal third-quarter, pointing to stronger US sales momentum tied to its turnaround plan, and it raised its full-year guidance.
THE APEX TIMES
A recent report argues Starbucks is getting back to the core test of retail success, whether shoppers believe the coffee run is worth the price. CEO Brian Niccol’s turnaround appears to be shifting perceptions just as he approaches a key two-year milestone.
THE APEX TIMES
The company reported additional momentum in U.S. comparable sales, pointing to ongoing changes aimed at improving speed and the in-store experience.
THE APEX TIMES
In remarks following the company’s fiscal third-quarter earnings release, Starbucks Chief Executive Officer Laxman Narasimhan linked performance to factors beyond new products, emphasizing the role of store placement and the experience it helps create.
THE APEX TIMES
A Yahoo Finance preview ahead of McDonald’s second-quarter results emphasized that investors are looking beyond the headline earnings and sales figures, tracking additional metrics analysts use to gauge restaurant momentum.
THE APEX TIMES
A recent market note highlighted that PepsiCo shares are among the names most watched by Zacks.com users, prompting a look at what could influence the stock next. The post itself did not outline new earnings, guidance, or major corporate actions.
THE APEX TIMES
A new Yahoo Finance market piece frames Costco’s decade-long stock performance through a simple scenario: what $1,000 invested 10 years ago would be worth today, underscoring how compounding can dominate results for patient investors.
